Summary

Meet our team and listen to our sponsored talk by Reinhold Horlacher, PhD, from trenzyme, on Wednesday, 11 November at 12:35 CET.

Our team

 Jelena Vjetrovic 
 Business Manager EMEA 
About Jelena Vjetrovic
Business Manager EMEA
Aucune information.
 Jean-Thomas ISSENHUTH 
 Business Manager EMEA 
About Jean-Thomas ISSENHUTH
Business Manager EMEA
Aucune information.

Talk: High-Yield Production of SARS-CoV-2 Proteins: From Small Scale Transfection to GMP Compliant Process.

To support research groups for development of serological tests, generation of high-affinity antibodies and new vaccine candidates, trenzyme has developed a platform for rapid production of high-quality recombinant SARS-CoV-2 proteins by transient transfection, high-producer cell lines and even GMP compliant production cell lines for development of the intranasal vaccine XPOVAX.

Presented by Reinhold Horlacher, PhD, Managing Director at trenzyme.

Wednesday, 11 November at 12:35 CET.

Our solutions for both protein and virus production

PEIpro® product range for a scalable viral vector production for Gene & Cell therapy.

FectoPRO® Transfection kit is specifically designed for enhanced Transient Gene Expression (TGE) in suspension CHO and HEK-293 cells in various serum-free media, using low DNA amount (< 1 µg/ml of cell culture).

General information

Registration link for virtual event: click here
Give your feedback!